Locations
Cambridge, MA, USA · Cambridge, MA, USA · Stow, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotech · Biotechnology · Drug Discovery · Healthcare · Health Care · Medical · Pharma · Pharmaceutical Manufacturing · Pharmaceuticals · Science and Engineering
Size
51 - 200 employees
Stage
Other
founded in
2012
Vaxess Technologies is developing the MIMIX™ sustained release patch technology, the easiest and most effective way to administer vaccines and therapeutics. For vaccines, the controlled release simulates the pace of a natural infection, helping the body produce a slow, strong, and enduring ramp-up of immune response, ultimately boosting a vaccine’s effectiveness. Engineered for stability, Vaxess’s patch does not require refrigeration and can be shipped to and applied in low resource settings.
Something looks off?